2022 annual financial data
NRX Pharmaceuticals 2022 Operating margin
NRX Pharmaceuticals 2022 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -44,335,000 USD and net income was -39,754,000 USD.
Operating cash flow was -39,755,000 USD.
Get free NRX Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -44,335,000 USD
- Net income
- -39,754,000 USD
- Operating cash flow
- -39,755,000 USD